
Tamigo 0.4mg Tablet
Marketer
Rhine Biogenics Pvt Ltd
Salt Composition
Tamsulosin (0.4mg)
Overview Tamigo 0.4mg Tablet
Alfaprost 0.4mg tablets, an alpha-blocker, treat benign prostatic hyperplasia (BPH) by easing urinary symptoms such as hesitancy. This medication doesn't shrink the prostate gland. Always follow your doctor's prescribed dosage and regimen. It can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Common side effects may include dizziness, backache, chest discomfort, ejaculatory dysfunction, and retrograde ejaculation. Report any persistent or bothersome side effects promptly to your physician. Lifestyle adjustments can aid symptom management. Void your bladder immediately upon feeling the urge, but avoid straining. Limit or avoid caffeinated and alcoholic beverages in the evening and several hours before sleep or outings. Before starting treatment, disclose all current medications and health conditions to your doctor. If cataract or glaucoma surgery is planned, inform your ophthalmologist about your Alfaprost use. Individuals with liver impairment require close monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Tamigo 0.4mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Tamigo 0.4mg Tablet
Managing benign prostatic enlargement
Major Benefits of Tamigo 0.4mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.4mg Tamigo tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Tamigo 0.4mg Tablet:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamigo 0.4mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The 0.4mg Tamigo tablet should be swallowed whole; avoid crushing, chewing, or breaking it. It can be taken with or without food, although consistent timing is recommended.
How Tamigo 0.4mg Tablet works:
Tamigo 0.4mg tablets contain an alpha-blocking agent. By relaxing the bladder neck and prostate muscles, they facilitate easier urination. This improves bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tamigo 0.4mg tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Tamigo 0.4mg Tablet use in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Tamigo 0.4mg Tablet while breastfeeding is likely unsafe. Available human data indicate potential transfer to breast milk, posing a risk to the infant. This medication is not intended for use in lactating individuals.
DrivingSAFE
Driving ability is typically unaffected by Tamigo 0.4mg Tablet.
KidneySAFE IF PRESCRIBED
Tamigo 0.4mg tablets are considered safe for individuals with kidney impairment; no dosage modification is typically necessary. Data on Tamigo 0.4mg tablet use in patients with end-stage renal disease, however, remains scarce. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, Tamigo 0.4mg tablets require careful administration. Dosage modification of Tamigo 0.4mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Tamigo 0.4mg Tablet :
For Tamigo 0.4mg Tablets, take a missed dose immediately if you remember. But, if your next dose is nearly due, omit the forgotten dose and resume your usual dosing pattern. Never take two doses at once.
Facts to Know About Tamigo 0.4mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
